Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat sodium for sepsis-related acute respiratory distress syndrome
ChiCTR2100049028Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sivelestat in acute respiratory distress syndrome (ARDS) and sepsis (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Oxygenation index. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
sivelestat
03
Conditions
acute respiratory distress syndrome (ARDS)sepsis
Beyond the preview
Go deeper on ChiCTR2100049028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049028.